ES2127261T3 - Preparacion farmaceutica destinada a la via transdermica. - Google Patents

Preparacion farmaceutica destinada a la via transdermica.

Info

Publication number
ES2127261T3
ES2127261T3 ES93401896T ES93401896T ES2127261T3 ES 2127261 T3 ES2127261 T3 ES 2127261T3 ES 93401896 T ES93401896 T ES 93401896T ES 93401896 T ES93401896 T ES 93401896T ES 2127261 T3 ES2127261 T3 ES 2127261T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
transdermic
preparation intended
intended
furancarboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93401896T
Other languages
English (en)
Inventor
Veronique Andrieu
Louis Henrion
Jean Montel
Alexander Wick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Application granted granted Critical
Publication of ES2127261T3 publication Critical patent/ES2127261T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

PREPARACION FARMACEUTICA DESTINADA A LA VIA TRANSDERMICA, CARACTERIZADA EN QUE CONTIENE LA ALFUZOSINA ((N-(3O RAPIL) TETRAHIDRO Y UNA MEZCLA COMPUESTA POR AGUA, POR UNO O VARIOS DISOLVENTES ORGANICOS Y POR UNO O VARIOS PROMOTORES DE ABSORCION.
ES93401896T 1992-08-05 1993-07-22 Preparacion farmaceutica destinada a la via transdermica. Expired - Lifetime ES2127261T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9209711A FR2694495B1 (fr) 1992-08-05 1992-08-05 Préparation pharmaceutique transdermique contenant de l'alfuzosine.

Publications (1)

Publication Number Publication Date
ES2127261T3 true ES2127261T3 (es) 1999-04-16

Family

ID=9432638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93401896T Expired - Lifetime ES2127261T3 (es) 1992-08-05 1993-07-22 Preparacion farmaceutica destinada a la via transdermica.

Country Status (10)

Country Link
US (1) US5523094A (es)
EP (1) EP0582502B1 (es)
JP (1) JP3723233B2 (es)
AT (1) ATE173927T1 (es)
CA (1) CA2101871C (es)
DE (1) DE69322328T2 (es)
DK (1) DK0582502T3 (es)
ES (1) ES2127261T3 (es)
FR (1) FR2694495B1 (es)
GR (1) GR3029315T3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5614210A (en) * 1995-03-31 1997-03-25 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of alfuzosin
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
IL120303A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
GB2352971A (en) * 1999-06-11 2001-02-14 Bambour Olubukola Omoyiola Transdermal administration of pharmaceuticals in prostate cancer and genito-urinary treatment
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
DE10359073B4 (de) * 2003-12-17 2006-03-02 Daimlerchrysler Ag Abgaskrümmer
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
CN116080189B (zh) * 2022-11-08 2024-12-03 南通大学 一种耐折叠高剥离覆铝织物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
LU86672A1 (fr) * 1986-11-19 1988-06-13 Oreal Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline

Also Published As

Publication number Publication date
EP0582502A1 (fr) 1994-02-09
US5523094A (en) 1996-06-04
FR2694495A1 (fr) 1994-02-11
DK0582502T3 (da) 1999-08-16
JPH06157315A (ja) 1994-06-03
CA2101871A1 (fr) 1994-02-06
DE69322328D1 (de) 1999-01-14
ATE173927T1 (de) 1998-12-15
FR2694495B1 (fr) 1994-09-23
DE69322328T2 (de) 1999-06-24
EP0582502B1 (fr) 1998-12-02
JP3723233B2 (ja) 2005-12-07
CA2101871C (fr) 2004-05-25
GR3029315T3 (en) 1999-05-28

Similar Documents

Publication Publication Date Title
ES2127261T3 (es) Preparacion farmaceutica destinada a la via transdermica.
DE50106562D1 (de) Kosmetische und pharmazeutische Öl-in-Wasser-Emulsionen von polyethermodifizierten Polysiloxanen
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ES2022660B3 (es) Pulverizador portatil de liquido, especial para el tratamiento de la vegetacion
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DK254787D0 (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
DE60316590D1 (en) N-ä2-CHLOR-4-Ä(6,7-DIMETHOXY-4-CHINOLYL)OXYÜPHENYLü-N'-(5-METHYL-3-ISOXAZOLYL)HARNSTOFFSALZIN KRISTALLINER FORM
DK0825857T3 (da) Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse
DE69310173D1 (de) Völlig integrierter optischer kreisel von sagnac typ
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
DE69006676D1 (de) Tripeptidverbindungen und ihre pharmazeutische Anwendung als Immunmodulatoren.
FI102169B (fi) 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lää keaineina
DE69806465D1 (de) Eine heteroethynylen-brücke enthaltende bi-aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
FI890370A0 (fi) Foereningar med psykotrop inverkan, dessa innehaollande laekemedel och deras anvaendning vid behandling och profylax av stoerningar i det centrala nervsystemet.
BR9701455A (pt) Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
FI931159A7 (fi) Dosaerosoler, som innehåller som aktivt ämne flezelastin och med detta relaterade strukturer
ATE76754T1 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
DK630088D0 (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
AR014352A1 (es) Mezclas fungicidas y procedimiento para controlar hongos nocivos con dichas mezclas
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 582502

Country of ref document: ES